A Dose Escalating Study to Assess the Safety and Tolerability of GT-001
Clinical trial NCT03490786 · COMPLETED
Trial details
- NCT number
- NCT03490786
- Sponsor
- Gila Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-16
- Primary completion
- 2017-08-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.